![]() Burning Rock Biotech Burning Rock Biotech (燃石医学) is a company that specializes in next-generation sequencing (NGS) diagnostics solutions for precision medicine in oncology. | ![]() ITeos Therapeutics ITeos Therapeutics is a pharmaceutical company that develops immunotherapy solutions. | ![]() Momotaro Gene Momotaro Gene is a company developing next-generation cancer therapeutics by gene therapy. | ![]() NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. | ||
Founding Date | Founding Date 2014 | Founding Date 2011 | Founding Date 2007 | Founding Date 2015 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Guang Zhou, CN HQ Beijing, CN Shanghai, CN Irvine, US | Locations Watertown, US HQ Charleroi, BE | Locations HQ | Locations Beltsville, US HQ | Locations Emeryville, US HQ Cambridge, US Menlo Park, US Pleasanton, US Redwood City, US |
Employees | Employees 674 | Employees 17310% increase | Employees N/A | Employees N/A | Employees 5 |
Valuation ($) | Valuation ($) 28.6 m | Valuation ($) 313.4 m | Valuation ($) N/A | Valuation ($) 39.2 m | Valuation ($) 3.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥539.6m (FY, 2025) | Revenue (est.) $35m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $16.3m (FY, 2023) |
Net income | Net income (¥55.3m) (FY, 2025) | Net income ($134.4m) (FY, 2024) | Net income N/A | Net income ($55.8m) (FY, 2025) | Net income ($138.5m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 149.2m | Total funding raised $ 215m | Total funding raised $ 9.6m | Total funding raised $ 160m | Total funding raised $ 195m |

ITeos Therapeutics is a pharmaceutical company that develops immunotherapy solutions.
View company
Momotaro Gene is a company developing next-generation cancer therapeutics by gene therapy.
View company
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
View company
Gritstone bio is a company that develops vaccines for cancers and infectious diseases.
View company